Introduction
Aging is associated with a decline in cognitive performance that begins around midlife (i.e., 45e50 years), but the onset and severity varies greatly among individuals (Davies et al., 2015; Singh-Manoux et al., 2012) . Although variation in cognitive performance at midlife is highly heritable [i.e., 62%e78% of variance is attributable to genetic factors (McClearn et al., 1997; Plomin and Deary, 2015) ], a large portion of this heritability remains unexplained by currently identified gene variants (Johnson et al., 2016) . Several studies have identified associations between apolipoprotein E, brain-derived neurotrophic factor, and catechol-O-methyltransferase with either cognitive ability or rate of cognitive decline in older people (Harris and Deary, 2011; Laukka et al., 2013; Payton, 2009; Tapia-Arancibia et al., 2008; Wisdom et al., 2011) . However, even when polymorphisms in these genes are significantly associated with cognitive phenotypes, effect sizes are typically small (Harris and Deary, 2011) , indicating that additional genes contribute significantly to the regulation of cognitive decline in human populations. The identification of specific genes that modify the development and progression of cognitive decline may aid in early diagnosis of at-risk patients, as well as identify novel targets for the development of therapeutics to prevent or delay the onset of disease.
Challenges to identifying DNA variants that modify cognitive aging in humans include substantial genetic heterogeneity, difficulty in controlling environmental factors, and limited molecular data from disease-relevant human brain tissue. To circumvent some of these challenges, murine genetic reference panels (GRPs) have been designed to model some of the genetic and phenotypic complexity of human populations (International HapMap et al., 2010; Peirce et al., 2004; Williams et al., 2001) , allowing a researcher to exploit phenotypic heterogeneity across a population while controlling for environmental factors (Williams and Auwerx, 2015) . One such model, a well-characterized GRP known as the BXDs (Peirce et al., 2004; Taylor, 1978; Taylor et al., 1999) , was derived by crossing 2 common inbred strains, C57BL/6J (B6) and DBA/2J (D2). The BXDs have been successfully used to identify genomic regions important for determining learning and memory capabilities early in life (Wehner et al., 1997) but have not yet been used to study cognitive aging. To identify genes and molecular pathways regulating memory capabilities during aging, here we perform a forward systems genetic analysis on an aged cohort of strains from the BXD GRP.
Methods

Animals
Male and female mice were group housed (2e5 per cage) and maintained in colony housing (12-hour light/dark cycle) with ad libitum access to food and water. All mouse experiments were conducted in accordance with the University of Tennessee Health Science Center Animal Care and Use Committee, the Institutional Committee on Animal Care and Use at the Hebrew University of Jerusalem, and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Middle-aged mice (15 AE 0.3 months, 2e8 mice per strain) from 21 BXD recombinant inbred strains were phenotyped. Although experiments in rodents using a single inbred strain are often carried out using 7e12 replicates (Kaczorowski and Disterhoft, 2009; Kaczorowski et al., 2011 Kaczorowski et al., , 2012 , mapping studies using the BXD panel gain much more power by increasing numbers of unique genotypes rather than replicates per strain (Belknap, 1998) . This is because at each locus, roughly half of the lines inherit B/B genotypes and the other half D/D genotypes (see Fig. 1B in Andreux et al., 2012) . The BXDs were derived by inbreeding the F2 progeny of a C57BL/6J (B6) and DBA/2J (D2) intercross to create a panel that models some of the genetic complexity of human populations (Chesler et al., 2005; International HapMap et al., 2010) . The parental strains, B6 and D2, differ in a variety of traits, including memory function (Balogh et al., 2002) , amyloid precursor protein processing (Lehman et al., 2003) , adult hippocampal neurogenesis (Kempermann et al., 2006) , and hippocampal excitability (Oksman et al., 2005) , which confers wide phenotypic variability to the resulting BXD strains. Each BXD line has been inbred for >20 generations, and their genomes are stable, which allows for replication studies across time and laboratories (Peirce et al., 2004) . In addition to collected "health records" at GeneNetwork.org, both genotype and transcriptome data for w40 tissues and cells, including hippocampus, have been generated for many of the strains, which we combined with full-sequence genome data for both B6 and D2 to facilitate genetic mapping to identify individual genetic variants that correlate with traits of interest (Chesler et al., 2005 Houtkooper et al., 2013; Wang et al., 2016) . Hp1bp3 tm1a(EUCOMM)Wtsi mice (n ¼ 6/group) were acquired from the European Conditional Mouse Mutagenesis program and are described elsewhere (Garfinkel et al., 2015a) .
Contextual fear conditioning
All mice were habituated to transport for at least 3 days before behavioral tests. On the fourth day, mice were trained on a standard contextual fear conditioning paradigm (Neuner et al., 2015) . Briefly, contextual fear conditioning consisted of a 180-second baseline period followed by 4 mild foot shocks (1 second, 0.9 mA, intershock interval 115 AE 20 seconds). The average activity burst following each shock was determined by manual timing and used to quantify the postshock reactivity for each mouse to ensure no difference in pain sensitivity. Twenty-four hours later, hippocampus-dependent contextual fear memory (Chen et al., 1996) was tested in a 10-minute session. Behavioral freezing, an index of conditioned fear, was measured using Freeze Frame software (Coulbourn Instruments, PA, USA) at the University of Tennessee or EthoVision software (Noldus Information Technology, Netherlands) at the Hebrew University of Jerusalem. Our laboratory has previously demonstrated that measures of freezing obtained via video monitoring software correlates well with hand-scored measures of freezing (Kaczorowski et al., 2012) . Experimenters were blind to the genotype during behavioral tests and data analysis.
Calculation of memory index for adult BXD strains
BXD strains aged 8e9 weeks had previously been subjected to contextual fear conditioning by Philip et al. (2010) . The data set used in our study (including males and females) is publically available on GeneNetwork.org as BXD Published Phenotypes Record ID 11908. The memory index used in Trait 11908 is a measure of activity (beam breaks) throughout contextual fear memory (CFM) testing. This measure of activity has been previously shown to correlate well with measures of hand-scored freezing behavior (Valentinuzzi et al., 1998) . As the dynamic range of humanobserved freezing behavior is 0%e100% (Anagnostaras et al., 2000) , and an activity score of zero is equivalent to 100% freezing, we subtracted these activity measures from 100 to obtain a measure of inactivity that parallels the CFM index (% freezing) calculated for middle-aged strains. Specifically, the mean time each adult BXD strain spent active during testing was subtracted from 100 to obtain a measure of inactivity. The genotype of each strain at the Hp1bp3 locus was then obtained from GeneNetwork.org and used for genotype-by-memory analyses.
T-maze
The T-maze test was performed as described previously (Deacon and Rawlins, 2006) . Mice were given 10 minutes to habituate to the testing room. The T-maze floor was coated with fresh woodchips before each round of trials. Mice were placed into the T-maze and allowed to choose 1 of 2 "goal" arms. The mouse was then confined to that arm for 30 seconds using a central partition. The mice were removed from the maze and immediately placed back at the starting point, the partition removed, and the mouse allowed to choose between the 2 goal arms again (Deacon and Rawlins, 2006 ). An "alternation" occurred when the mouse entered the opposite arm than that to which it was just confined. The criterion point used was whole animal in goal arm, including tail tip. A total of 6 trials were performed, with animals tested no more than twice a day. The alternation scores across all 6 trials were averaged to obtain an average alternation score for each mouse.
Quantitative trait locus (QTL) identification and candidate gene selection
After CFM tests for 21 BXD strains were completed, the mean time spent freezing was averaged for each strain. Strain means were entered in GeneNetwork.org and are publically available as BXD Published Phenotypes Record ID: 18395. Hippocampal transcript data from aged BXD strains available on GeneNetwork.org as UTHSC BXD Aged Hippocampus Affy MoGene1.0ST (May15) RMA Gene Level, were used to identify cis (locally)-regulated genes (Andreux et al., 2012; Chesler et al., 2005) from within intervals of interest. The same transcript data were used to identify genes whose expression correlated with memory function in aged animals. Only probes that did not overlap single nucleotide polymorphisms (SNPs) were used to avoid hybridization artifacts that may cause apparent differences in expression due to technical rather than biological variance. When multiple SNP-free gene level probes were available (e.g., Hp1bp3), the mean expression of exon-targeting probes was used. In cases where SNP-free gene level probes were not available, exonlevel hippocampal transcript data from aged BXD strains were used (UTHSC BXD Aged Hippocampus Affy Mouse Gene1.0ST (Sep12) RMA Exon Level, data set accession ID GN392). If exon level probes were used, the probe with highest average expression across all strains was selected. All probes were verified by BLAT (UCSC Genome Browser). Correlation analyses for initial candidate gene prioritization used Spearman's rho and were adjusted for multiple comparisons using Bonferroni correction (95% CI).
Western blots
Western blots were performed as previously described (Hatfield et al., 2015; Neuner et al., 2015) . Frozen human hippocampal samples (n¼3/group) collected postmortem were obtained from the University of Kentucky Sanders-Brown Center on Aging and stored at À80 C until use. Briefly, hippocampal lysates were prepared from frozen tissue, protein concentration was determined using a Nanodrop2000 Spectrophotometer (ThermoScientific), and 20 mg of total protein was loaded and separated on a 10% SDS-PAGE gel. Proteins were transferred using the Bio-Rad TurboTransfer system and blocked for 30 minutes at room temperature. Primary antibodies for HP1BP3 and GAPDH (ProteinTech #24556-1-AP and Fitzgerald #10R-G109a, respectively) were incubated overnight and detected by anti-mouse and anti-rabbit fluorescent-conjugated antibodies. Visualization was performed using an Odyssey image scanner and blots were quantified using the Odyssey software version 5.0 (LiCOR). Results were replicated in 2 independent Western blots. Observed double-band staining is the typical expression pattern for HP1BP3 (Garfinkel et al., 2015b) and overlaps with positive control HP1BP3 overexpression lysate from human 293T cells (Abnova #H00050809-T02), which was used as a positive control. Loading dyeeonly lanes served as negative control.
Gene set enrichment analysis
Gene set enrichment analysis was performed as described previously using version 2.2.0 (Mootha et al., 2003; Subramanian et al., 2005) . Briefly, all nominally significant correlates of hippocampal Hp1bp3 were extracted from whole-genome hippocampal transcript data from BXD strains age-matched to those used for contextual fear conditioning. Correlates were ranked based on correlation coefficient, and this preranked list was used to calculate an enrichment score for gene sets obtained from the Molecular Signatures Database version 5.0. Enrichment scores are obtained by calculating a cumulative ("running-sum") statistic, which is increased when a gene is present in the set being tested and decreased when a gene is not. The maximum deviation of this cumulative score from 0 is the enrichment score. Then, normalized enrichment scores were obtained to account for the size of the gene set being tested. The proportion of false positives was controlled using established methods (Mootha et al., 2003; Subramanian et al., 2005) . Based on these criteria, any gene set with a false discovery rate of 0.25 was accepted as significantly enriched in our data set.
Statistical analysis
Statistical analysis was performed using SPSS software (IBM) and Microsoft Excel. Analyses included independent t-tests, repeated measures, 1-way and 2-way analysis of variance, and Pearson correlation with confidence level set at p < 0.05. All analyses were corrected for multiple comparisons and described in the Section 3. Unless otherwise stated, data values reported here are given as mean AE standard error of the mean. The order of behavioral tests and mice allocated to each condition were randomized. The experimenter was blind to group allocation for all behavioral studies, and analysis of raw data was conducted blind to experimental groups.
Results
Genetic mapping identifies an interval on chromosome 4 associated with memory status at midlife
To identify genes involved in the regulation of cognitive aging, we analyzed hippocampus-dependent memory function across a cohort of middle-aged mice (15 AE 0.3 m) that model the genetic and phenotypic variation of human populations (the BXD genetic reference panel, Fig. 1A ). Specifically, mice were trained on standard contextual fear conditioning (Kaczorowski and Disterhoft, 2009) . During training on day 1, mice received 4 scrambled foot shocks in the conditioning chamber over a 10-minute training session. Twenty-four hours later, mice were returned to the original conditioning chamber, and the percentage of time each mouse spent freezing over the 10-minute test was measured as an index of CFM. CFM is highly variable across this aged BXD family (21 strains tested, n ¼ 2e8 mice/strain, Fig. 1B) , and heritability estimates that compare the observed genetic (between-strain) variance to technical (within-strain) variance (heritability, h 2 z 0.7) demonstrate that much of this variability is attributable to genetic factors.
Although strain-specific differences in acquisition were also observed, the variance in acquisition was not sufficient to explain the differences in CFM across the panel. Subsequent interval mapping using the average memory index for each strain highlighted a region of chromosome 4 (Chr 4, 137.7e140.5 Mb) that was significantly associated with variation in CFM in middle-aged mice (Fig. 1C) . This QTL had not associated with memory function in studies using younger adult sex-matched BXDs (Philip et al., 2010) , suggesting the QTL contains variants that contribute to variation in cognitive aging as opposed to general memory function.
Prioritization of positional candidates identifies Hp1bp3 as putative regulator of cognitive aging across BXD panel
To identify genes located in the QTL that may be causally involved in regulating CFM abilities at midlife, positional gene candidates were prioritized based on the following: (1) annotated sequence differences segregating among the BXD strains, (2) local control of gene expression as determined by expression QTL analysis using hippocampal transcriptome data from aged BXD strains, and (3) significant correlation between hippocampal gene expression and CFM. The gene heterochromatin protein 1 binding protein 3 (Hp1bp3) emerged as the single best positional candidate (Table 1) .
Hp1bp3 contains multiple missense variants in coding regions, numerous noncoding variants, and insertions and/or deletions predicted to impact protein function, transcriptional regulation and/or splicing Supplementary Table 1) . Hippocampal Hp1bp3 expression was significantly correlated with CFM status, with those BXD strains inheriting the D parental allele exhibiting lower levels of Hp1bp3 transcript and worse CFM performance relative to the B allele (Fig. 1D) . Although Hp1bp3 genotype had no effect on memory status in younger adult mice (age of 8e9 weeks, Fig. 2A , secondary analysis of data from Philip et al., 2010) , strains inheriting the D allele exhibited significantly impaired CFM at midlife (Fig. 2B) . Because variation in the CFM index at midlife was not due to genetic differences in baseline anxiety or postshock pain sensitivity confounds (Fig. 3) , these data suggest a genotype-by-age interaction in which reductions in Hp1bp3 expression correspond specifically to aging-related cognitive impairment (Figs 1e3). In support, the genotype at Hp1bp3 can account for as much as 52% of the strain variance in CFM performance at midlife. However, calculations of genetic variance Genes located under the significant CFM QTL were first prioritized for presence of annotated sequence variants between parental strains B6 and D2. Whole-genome transcript data from aged BXD strains were then used to perform expression QTL mapping, and those genes whose expression had a peak LRS at the location of the gene (cis, or locally, regulated genes) were given higher priority. These genes were tested for correlation with the CFM trait using SNP-free probes from gene-level analyses (or exon-level analyses where necessary, see Section 2.5). Spearman's rho correlations are reported. Key: CFM, contextual fear memory; LRS, likelihood ratio statistic; N.S., not significant; QTL, quantitative trait locus. a Denotes SNP-free probe.
explained by a QTL are biased upward by an average of 30% due to a combination of epistatic, genotype-by-environment interactions, and small sample size (n < 1000) (Beavis, 1998; Wellenreuther and Hansson, 2016; Wurschum and Kraft, 2014) . Therefore, we estimate that the actual biological heritable variation in CFM at midlife explained by Hp1bp3 genotype is more likely in the range of 20%e25%.
Functional validation in a knockout (KO) mouse model confirms novel role for Hp1bp3 in cognitive function
To assess the functional consequence of loss of Hp1bp3 on hippocampus-dependent learning and memory, we employed a reverse genetics approach. During CFM training, Hp1bp3 KO and wild-type (WT) mice (Garfinkel et al., 2015a) showed no differences in baseline activity (Fig. 4A) or shock reactivity (Fig. 4B) , and KO mice exhibited comparable acquisition of conditioned fear, indicating they successfully learned the context-shock association (Fig. 4A) . Nevertheless, KO mice exhibited long-term CFM deficits when tested 24 hours later (Fig. 4C) . Notably, the effect of Hp1bp3 KO on CFM was similar to the effect of genotype at the Hp1bp3 locus. As the KO mice were generated on a B6 background, the WT mice carry the B version of the Hp1bp3 allele, and as expected, perform comparable to B6 mice from the BXD GRP. However, KO mice performed more similarly to BXDs harboring the D allele, which exhibited a 20%e40% reduction in conditioned freezing during CFM tests compared to strains with the B allele (Fig. 2B) . This suggests the D allele functions similarly to a loss-of-function mutation.
To determine if loss of Hp1bp3 mimics aging-related effects on additional hippocampus-dependent cognitive domains (Zornetzer et al., 1982) , working memory was assessed using the T-maze test of spontaneous alternation (Deacon and Rawlins, 2006) . KO mice were significantly impaired relative to WT mice, and like aged mice (Lalonde, 2002) , performed at chance levels (Fig. 4D) . Taken together, these results demonstrate, for the first time, that Hp1bp3 is necessary for successful hippocampus-dependent memory function spanning multiple cognitive domains and suggest that therapeutic interventions to restore levels of Hp1bp3 may improve cognitive function.
Hp1bp3 is associated with memory function in human cognitive aging
To test the hypothesis that Hp1bp3 is also involved in human cognitive aging and to evaluate the translational relevance of our murine results, we next tested whether hippocampal Hp1bp3 expression correlated with cognitive performance in elderly humans (Table 2 ). Caveats to working with human brain samples include variable postmortem intervals and undefined brain pathology (Bennett et al., 2014; Hargis, 2016) . Therefore, to limit potential confounds we analyzed hippocampal tissue from humans with "normal" cognitive aging (i.e., no distinct Alzheimer's disease [AD] pathology), which is not typically associated with gross neurodegeneration (Burke and Barnes, 2006; Korbo et al., 2004 lower in humans diagnosed with cognitive impairment compared with age-matched controls (Fig. 5) . Double-band staining is typical of HP1BP3 expression, indicative of multiple splice variants present in brain tissue (Garfinkel et al., 2015b) . These results suggest either lower or reduced expression of Hp1bp3 may underlie cognitive deficits observed in human populations and highlight the value and potential relevance of aged cohorts of diverse strains of mice for identifying molecular correlates of cognitive decline in humans.
Genetic correlation analyses elucidate functional roles for Hp1bp3 in cognitive aging
There is evidence that groups of highly correlated genes are likely to play a similar biological function and/or act as part of the same biological pathway (Eisen et al., 1998; Zhang and Horvath, 2005) . To identify mechanisms through which Hp1bp3 may act to regulate cognitive abilities at midlife, genes whose hippocampal expression significantly correlated with that of Hp1bp3 were identified using whole-genome hippocampal transcript data from middle-aged BXD strains. All nominally significant correlates (uncorrected p 0.05, 2074 genes) were sorted into a ranked list, with the most highly positively correlated genes at the top (Supplementary Table 2) . This list was then used for gene set enrichment analysis (Broad Institute (Subramanian et al., 2005) ; and tested against gene sets publicly available from Broad Institute's Molecular Signatures Database, including Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (Kanehisa and Goto, 2000) , Reactome pathways (Matthews et al., 2009) , and Gene Ontology (GO) classification (Harris et al., 2004) , using a false discovery rate of 0.25 to identify significantly enriched gene sets per standard methods (Subramanian et al., 2005) .
Functions of Hp1bp3 that have been identified include regulation of chromatin structure (Dutta et al., 2014) , gene expression (Garfinkel et al., 2015b) , cell cycle progression (Dutta et al., 2014) , and insulin signaling (Garfinkel et al., 2015a) , several of which were supported by our analyses. For example, positive correlates of Hp1bp3 were significantly enriched both in nuclear localization (Fig. 6A) and insulin signaling (Fig. 6B) . In addition, we found Hp1bp3 gene correlates enriched for terms related to plasma membrane localization and for functions related to neuronal function and excitability, including voltage-gated channel activity, ion channel activity, and G-protein coupled receptor activity (Fig. 6C) . Together, these results support the hypothesis that Hp1bp3 may critically influence expression of ion channels and receptors located in the plasma membrane that mediate neurogenesis, neuronal excitability, and plasticity; all of which are mechanisms that are disrupted in hippocampal neurons of aged rodent models with cognitive deficits (Burke and Barnes, 2006; Kaczorowski and Disterhoft, 2009; Mattson and Magnus, 2006) . Finally, Hp1bp3 gene correlates also show significant overlap with genes differentially expressed between AD patients and controls (Blalock et al., 2004 ; Fig. 6D ), suggesting the role of Hp1bp3 in cognitive aging may extend into the regulation of cognitive deficits observed in AD.
Discussion
The goal of this study was to use a genetically diverse panel of mice to identify genetic factors involved in the regulation of cognitive aging that may have gone undetected in either complex human studies or murine studies utilizing only a single genetic background. Aging is a leading risk factor for age-associated dementias such as AD, and our work and others suggest that genetic factors and mechanisms underlying biological processes during midlife play a key role in determining an individual's susceptibility or resilience to transitioning between healthy brain aging and pathological brain aging (Douaud et al., 2013; Jack et al., 2013; Kaczorowski et al., 2011; Keller, 2006; Miller et al., 2008) . Thus, there is a critical need to understand gene variants that play a role in determining memory capabilities at this midlife transition point. To directly address this need, and to overcome some of the barriers inherent to human studies, we turned to a well-characterized murine GRP, which allows for the exploitation of phenotypic heterogeneity across a population while exerting precise control of environmental conditions.
Identification and validation of Hp1bp3 as top positional candidate modulating cognitive aging
By combining forward and reverse murine genetic approaches and by joint analysis of mouse and human cohorts, we progressed from the identification of a significant QTL containing variants regulating CFM at midlife to the demonstration that our top positional candidate, Hp1bp3, is important for hippocampus-dependent long-term CFM and spatial working memory. Knockout of Hp1bp3 has been associated with viability and growth abnormalities (Garfinkel et al., 2015b ) that may affect behavior. Therefore, we examined the behavior of Hp1bp3 KO mice on 3 tasks that may confound CFM testing (e.g., baseline exploratory activity, postshock reactivity, and acquisition of contextual fear). We found no differences between the Hp1bp3 KO and WT mice on these measures, suggesting that the effects of Hp1bp3 KO reported herein are not due to gross behavioral abnormalities. Other positional candidates identified in the CFM QTL, such as Pink1 and Kif17 (Table 1) , have been linked to cognitive deficits (Roberson et al., 2008) and neurodegeneration (Moisoi et al., 2014) Fig. 6 . Gene set enrichment analysis. All nominally significant hippocampal correlates (uncorrected p 0.05, n ¼ 2074, see Supplementary Table 2) of Hp1bp3 were extracted from whole-genome transcriptome data from BXD strains age-matched to those used for contextual fear conditioning. The genes were sorted based on correlation coefficient, with the most highly positively correlated genes at the top of the list. Graphs illustrate calculation of enrichment score or deviation from random distribution throughout the preranked list. Each vertical black line below the graph represents a gene set member and its position in the preranked list (red ¼ genes positively correlated with Hp1bp3, blue ¼ genes negatively correlated with Hp1bp3). A false discovery rate (FDR) cutoff of q 0.25 was used to identify significantly enriched sets according to established methods. (A, top) Positive correlates were significantly enriched for localization to the nucleus. (A, bottom) Genes localized to the nucleus were also present in significantly enriched functional gene sets including RNA splicing, nuclear transport, chromosome organization, cell cycle, and transcription cofactor activity. Normalized enrichment score represents enrichment score after adjustment to account for size of the given gene set. (B) Positive correlates were significantly enriched for the KEGG pathway corresponding to insulin signaling. (C, top) Negative correlates of Hp1bp3 were significantly enriched for localization to the plasma membrane. (C, bottom) Genes localized to the plasma membrane were also present in significantly enriched functional gene sets including ion channel activity, substrate-specific channel activity, transmembrane transporter activity, voltage-gated channel activity, and G-proteinecoupled receptor activity. (D) Correlates of Hp1bp3 also show significant overlap with a set of genes determined by Blalock et al. (2004) to be significantly differentially expressed between AD patients and corresponding controls. Abbreviation: GO, gene ontology.
hippocampal-dependent nature of contextual fear conditioning (Chen et al., 1996) and the fact that the hippocampus is one of the first structures affected in aging (Burke and Barnes, 2006; Gant et al., 2006) . However, given that the formation and recall of CFM involves a distributed network of brain regions (Tovote et al., 2015) , it is possible that altered gene expression in other regions (e.g., prefrontal cortex) may also contribute to variation in cognitive aging. As variation in Hp1bp3 genotype was estimated to account for w20%e25% of the heritable variation in CFM at midlife, it is possible that additional genes, acting alone or in combination with Hp1bp3, also influence some of the observed variation in cognitive decline, and further investigation into these candidates is warranted.
Hp1bp3 likely plays conserved role in humans
Reduced expression of Hp1bp3 is observed in both cognitively impaired aged mice and humans, suggesting that decreased expression of Hp1bp3 contributes to cognitive aging in both species. In support of this idea, Hp1bp3 is among the top 100 genes upregulated in response to metformin hydrochloride (Lamb et al., 2006) , a drug known to enhance memory in mice (Wang et al., 2012) , which was recently approved for clinical trial to prevent or reduce effects of aging, including cognitive decline (Targeting Aging with Metformin, TAME study). In addition, Hp1bp3 is highly conserved in mammals, with 93% similarity between the human and murine primary sequences (Garfinkel et al., 2015b) indicating Hp1bp3 likely plays an important functional role in both species. Deletion of the region of the human genome syntenic to our QTL results in a condition known as deletion 1p36 syndrome (Battaglia et al., 2008) . Although specific phenotypes vary according to size and location of deletion breakpoint (Gajecka et al., 2007) , many with this syndrome exhibit cognitive deficits and mental retardation (Battaglia et al., 2008) , supporting the idea that genes in this area are necessary for cognitive function in both humans and animals.
Gene set enrichment analyses highlight putative functional roles for Hp1bp3
Hp1bp3 has been shown to be evolutionarily and structurally related to the linker histone H1 family, members of which confer higher-order organization to chromatin by binding to the surface of nucleosomes (Garfinkel et al., 2015b) . A number of studies suggest this family of proteins plays a highly specific role in gene expression, possibly because of their role in chromatin organization (Garfinkel et al., 2015b) . It is thought that Hp1bp3 contributes to the interconversion of heterochromatin and euchromatin (Dutta et al., 2014) , thereby activating or silencing specific genes as needed. As long-term memory and cognition depend on de novo gene expression in response to learning and/or training event (Cavallaro et al., 2002) , it is possible that Hp1bp3 is regulating the transcription of specific genes necessary for successful cognitive function. Genes significantly positively correlated with Hp1bp3 were enriched for localization in the nucleus, with functions including transcription and RNA processing. Genes negatively correlated with Hp1bp3 include genes with known links to cognition and neuron function, such as channel and transporter activity (Fig. 6C) . In addition, genes effected by Hp1bp3 knockdown in cell lines are known to have important neuronal and/or memory functions in vivo, including the regulation of neuronal excitability (Averaimo et al., 2014; Gulledge et al., 2013; Richards et al., 2007) , Ca 2þ homeostasis (Jia et al., 2015) , synaptic plasticity (Lee et al., 2012) , and inhibitory neurotransmission (Marsden et al., 2007) in the hippocampus (e.g., Ca 2þ ATPase, Na þ /K þ ATPase, CLCC1 and CLIC channels, and GABARAP). However, our gene set enrichment analysis results do not differentiate whether changes in nuclear or plasma membrane proteins occur first, so it is possible that compensatory changes in transcription and RNA processing are occurring due to aging-induced alterations in plasma membrane ion channels and receptors. A targeted in vivo knockdown of Hp1bp3 and subsequent gene expression analysis will help to clarify the role of Hp1bp3 in gene expression under physiological conditions.
Conclusion
Here, we demonstrate for the first time that Hp1bp3 is a key modulator of cognitive aging. In addition, although the BXD family has previously been used to study cognition in young mice (Philip et al., 2010; Wehner et al., 1997) , but Hp1bp3 had not emerged as a key regulator of CFM, our results suggest that variation in Hp1bp3 genotype may influence memory in an age-dependent manner. As biological processes regulating memory function at midlife may play a critical role in the development of AD dementia (Douaud et al., 2013; Jack et al., 2013; Kaczorowski et al., 2011; Keller, 2006; Miller et al., 2008) and Hp1bp3 gene correlates also show significant overlap with genes differentially expressed between AD patients and controls (Blalock et al., 2004 ; Fig. 6D ), we speculate that treatments that restore Hp1bp3 expression and/or function may improve cognition in patients with normal cognitive decline as well as AD dementia. This prediction is further supported by evidence that metformin hydrochloride, a drug known to increase Hp1bp3 expression (Lamb et al., 2006) , has been shown to enhance memory in mice (Wang et al., 2012) and is approved for an antiaging clinical trial in humans (Targeting Aging with Metformin, TAME study). Overall, our results suggest Hp1bp3 and related networks may serve as potential targets against cognitive aging and demonstrate the utility of genetically diverse mouse models for the study of complex human disease.
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